|
Re: Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 27, 2018 05:20AM
|
|
Re: Feb. 06, 2019 FMV ZENE!
|
2
|
Zenith Epigenetics
|
Feb 07, 2019 02:42PM
|
|
Re: For The Record
|
2
|
Zenith Epigenetics
|
Sep 28, 2022 04:48PM
|
|
Re: New Share Price Contest
|
2
|
Resverlogix Corp.
|
Oct 11, 2019 12:57PM
|
|
Re: June 30-July 02, 2016: 9th World Drug Delivery Summit
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 05, 2016 07:24PM
|
|
Re: Zenith or Rvx in play...
|
2
|
Resverlogix Corp.
|
Oct 02, 2016 05:00PM
|
|
Re: Lowest volume in a long time?
|
2
|
Resverlogix Corp.
|
Dec 18, 2018 09:28AM
|
|
Re: RVX Price has nearly doubled in the past two days ...
|
2
|
Resverlogix Corp.
|
Feb 02, 2023 09:14PM
|
|
Re: The Feb 26th DSMB PR.....re-examined.
|
2
|
Resverlogix Corp.
|
May 15, 2018 06:47AM
|
|
Re: Could there be another shoe waiting to drop?
|
2
|
Resverlogix Corp.
|
May 19, 2019 09:50AM
|
|
Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
2
|
Resverlogix Corp.
|
May 02, 2021 09:44PM
|
|
Re: When to expect the 250th Event
|
2
|
Resverlogix Corp.
|
Feb 26, 2019 04:19PM
|
|
Re: Proactive Article - new presentation on website
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 23, 2020 10:40AM
|
|
Re: Share price, why we stay
|
2
|
Resverlogix Corp.
|
Nov 18, 2020 12:21PM
|
|
Re: Genentech/Roche BET inhibitor toxicity paper
|
3
|
Resverlogix Corp.
|
Apr 19, 2016 05:08PM
|
|
Re: When to expect the 250th Event
|
3
|
Resverlogix Corp.
|
Feb 26, 2019 04:30PM
|
|
Re: Denali/Sirion deal to get AAVs across the BBB
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jan 09, 2019 03:43PM
|
|
Re: AGM Tuesday 12/12 1:30 PM MT
|
3
|
Resverlogix Corp.
|
Dec 12, 2017 11:27AM
|
|
Re: Some history
|
3
|
Resverlogix Corp.
|
Jan 25, 2023 05:09AM
|
|
Re: And we wait.....
|
3
|
Zenith Epigenetics
|
Jan 30, 2018 07:41AM
|
